Characterization of extracellular dopamine clearance in the medial prefrontal cortex: Role of monoamine uptake and monoamine oxidase inhibition

Journal of Neuroscience

Volumn 21, Issue 1, 2001, Pages 35-44

  Wayment, Hollie K ^a,b   Schenk, James O ^a   Sorg, Barbara A ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Ischemia Technologies   (United States)

Author keywords

Cocaine; Dopamine; Dopamine transporter; Medial prefrontal cortex; Monoamine oxidase; Rotating disk electrode voltammetry

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); CLORGYLINE; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; MONOAMINE; MONOAMINE OXIDASE INHIBITOR; NIALAMIDE; NORADRENALIN TRANSPORTER; NORADRENALIN UPTAKE INHIBITOR; PARGYLINE; SELEGILINE; SODIUM ION;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; ENZYME INHIBITION; EXTRACELLULAR SPACE; IN VITRO STUDY; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; POTENTIOMETRY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; TRANSPORT KINETICS;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BIOGENIC MONOAMINES; CARRIER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; ELECTROCHEMISTRY; ELECTRODES, IMPLANTED; EXTRACELLULAR SPACE; HOMOVANILLIC ACID; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICRODIALYSIS; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PARGYLINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; SYMPORTERS;

EID: 0035144799     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Protein kinase A kinetically upregulates the striatal transporter for dopamine
2. Reduction of prefrontal glucose metabolism common to three types of depression
3. Chronic L-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of attention-deficit/hyperactivity disorder
4. Short-term treatment of mood disorders with standard antidepressants
5. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine
6. Effect of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum
7. Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkey
8. Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake
9. In vivo assessment of dopamine uptake in rat medial prefrontal cortex: Comparison with dorsal striatum and nucleus accumbens
10. The new generation of monoamine oxidase inhibitors
11. The dopamine transporter: Immunochemical characterization and localization in brain
12. On some functions of the human prefrontal cortex
13. Prefrontal cortical-amygdalar metabolism in major depression
14. Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward
15. Rotating disk electrode voltammetric measurements of dopamine transporter activity: An analytical evaluation
16. Resolution of biogenic amine transporter kinetics by rotating disk electrode voltammetry: Methodology and mechanistic interpretations
17. Cocaine-sensitive and -insensitive dopamine uptake in prefrontal cortex, nucleus accumbens and striatum
18. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18] fluorodopa positron emission tomographic study
19. Severe disturbance of higher cognition after bilateral frontal lobe ablation: Patient EVR
20. Effect of L-deprenyl, its structural analogues and some monoamine oxidase inhibitors on dopamine uptake
21. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: An in vivo voltammetric study
22. Evoked extracellular dopamine in vivo in the medial prefrontal cortex
23. Cortical dopaminergic involvement in cocaine reinforcement
24. Cloning and characterization of two human polyspecific organic cation transporters
25. Selective substrates for non-neuronal monoamine transporters
26. Cocaine: Comparative effect on dopamine uptake in extrapyramidal and limbic systems
27. Behavioral properties of GBR 12909 and GBR 13098: Specific inhibitors of dopamine uptake
28. Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma
29. Prefrontal cortex lesions differentially disrupt cocaine-reinforced conditioned place preference but not conditioned taste aversion
30. Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex
31. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine
32. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat
33. Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: Implications for electroconvulsive therapy and transcranial magnetic stimulation in depression
34. Behavioral and neurochemical effects of acute and daily cocaine administration in rats
35. Metabolism of (-)deprenyl to amphetamine and methamphetamine may be responsible for (-)deprenyl's therapeutic benefit: A biochemical assessment
36. Brain dialysis: In vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats
37. The possible mechanisms of action of (-)deprenyl in Parkinson's disease
38. The pharmacological profile of (-)deprenyl (Selegiline) and its relevance for humans: A personal view
39. The monoamine oxidase inhibitors clorgyline and L-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by rat brain synaptosomal preparations
40. 3H]quinpirole binding in rat striatal membranes
41. 3H]quinpirole binding in brain by monoamine oxidase inhibitors: Evidence for a potential novel binding site
42. A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine
43. Effect of medial prefrontal cortex injections of SCH 23390 on intravenous cocaine self-administration under both a fixed and progressive ratio schedule of reinforcement
44. Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement
45. Kinetic evaluation of the commonality between the site(s) of action of cocaine and some other structurally similar and dissimilar inhibitors of the striatal transporter for dopamine
46. Measurement of time-resolved kinetics of biogenic amine release and transporter activity by rotating disk electrode voltammetry in vitro. Neuromethod 27
47. D2 receptors may modulate the function of the striatal transporter for dopamine: Kinetic evidence from studies in vitro and in vivo
48. Repeated cocaine and stress increase dopamine clearance in rat medial prefrontal cortex
49. Prefrontal cortical dysfunction in depression determined by Wisconsin card sorting test performance
50. Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: Comparison to amphetamine
51. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys
52. Deprenyl alters behavior and caudate dopamine through an amphetamine-like action
53. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum
54. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration
55. A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine
56. Expression of cocaine sensitization: Regulation by the medial prefrontal cortex
57. Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task
58. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression
59. Supersensitivity to the reinforcing effects of cocaine following 6-hydroxydopamine lesions to the medial prefrontal cortex in rats
60. D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat
61. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter
62. An in vivo study of dopamine release and metabolism in rat brain regions using intracerebral dialysis
63. Repeated daily cocaine alters subsequent cocaine-induced increase in extracellular dopamine in the medial prefrontal cortex
64. Increase of extracellular dopamine in the prefrontal cortex: A trait of drugs with antidepressant potential?
65. The effect of deprenyl (Selegiline) on the natural history of Parkinson's disease
66. Synaptic basis of cortical persistent activity: The importance of NMDA receptors to working memory
67. Neurodevelopmental perspectives on schizophrenia
68. Dopamine uptake in five structures of the brain: Comparison of rate, sodium dependence and sensitivity to cocaine
69. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex
70. The frontal cortex-basal ganglia system in primates
71. Effects of lesions of prefrontal cortex, amygdala, or fornix in behavioral sensitization to amphetamine: Comparison with N-methyl-D-aspartate antagonists
72. 2) and evidence for the expression of the transporter in the brain
73. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance
74. The effects of repeated doses of (-)deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline